2,178
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro

, , , , , , , , & show all
Pages 779-789 | Received 03 Dec 2022, Accepted 13 Apr 2023, Published online: 09 May 2023

References

  • Arai K, Jin G, Navaratna D, Lo EH. 2009. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 276(17):4644–4652.
  • Barthels D, Das H. 2020. Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 1866(4):165260.
  • Bavelloni A, Ramazzotti G, Poli A, Piazzi M, Focaccia E, Blalock W, Faenza I. 2017. MiRNA-210: a current overview. Anticancer Res. 37(12):6511–6521.
  • Beck H, Plate KH. 2009. Angiogenesis after cerebral ischemia. Acta Neuropathol. 117(5):481–496.
  • Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, Donnan GA. 2019. Ischaemic stroke. Nat Rev Dis Primers. 5(1):70.
  • Chang X, Fang Y, Zhang Y, Liu Y, Fan L, Nan L, Xu W, Lin Y, Chu K, Yan G. 2021. Gualou Guizhi Granule suppresses LPS-induced inflammatory response of microglia and protects against microglia-mediated neurotoxicity in HT-22 via Akt/NF-κB signaling pathways. Evid Based Complement Alternat Med. 2021:9957459.
  • Chen Y, Chen L, Tao J. 2013. Clinical research on treating limbs spasm from cerebral apoplexy with the Gualou Guizhi decoction. Clin J Chin Med. 5:7–9.
  • Chen J, Cui X, Zacharek A, Jiang H, Roberts C, Zhang C, Lu M, Kapke A, Feldkamp CS, Chopp M. 2007. Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol. 62(1):49–58.
  • Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 32(4):1005–1011.
  • Gentile C, Muise-Helmericks RC, Drake CJ. 2013. VEGF mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation. Dev Biol. 373(1):163–175.
  • Greenberg DA, Jin K. 2013. Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci. 70(10):1753–1761.
  • Jiang YL, Liu WW, Wang Y, Yang WY. 2020. MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway. Eur Rev Med Pharmacol Sci. 24:4971–4978.
  • Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 25(9):1794–1798.
  • Kuo PC, Weng WT, Scofield BA, Furnas D, Paraiso HC, Intriago AJ, Bosi KD, Yu IC, Yen JH. 2020. Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke. Blood Adv. 4(18):4366–4381.
  • Lin L, Cheng X, Lin Z, Gao YL, Lai JH. 2018. Therapeutic observation of acupoint iontophoresis with Gualou Guizhi decoction for spastic foot drop after cerebral stroke. Shanghai J Acu-Mox. 37:746–750.
  • Lin Y, Xu W, Xu W, Huang WQ, Zhang YQ, Li H, Chu KD, Chen LD. 2015. Simultaneous determination of 41 components in Gualou Guizhi granules by UPLC coupled with triple quadrupole mass spectrometry. Anal Methods. 7(19):8285–8296.
  • Lin Y, Xu W, Zhang Y, Li H, Xu W. 2015. Anti-apoptosis effect of Gualou Guizhi granule on neurons in ischemic stroke rats and primary hippocampal neurons. Rehabil Med. 25(1):38–43.
  • Luo SP, Fang YL, Chang XN, Zhang YQ, Chu KD. 2022. Effects of Gualou Guizhi granules on endoplasmic reticulum stress and apoptosis in brain tissue of the cerebral ischemic area of cerebral ischemia–reperfusion injury model rats. J Tradit Chin Med. 63:72–77.
  • Nan L, Xie Q, Chen Z, Zhang Y, Chen Y, Li H, Lai W, Chen Y, Huang M. 2020. Involvement of PARP-1/AIF signaling pathway in protective effects of Gualou Guizhi decoction against ischemia–reperfusion injury-induced apoptosis. Neurochem Res. 45(2):278–294.
  • Rahmati M, Ferns GA, Mobarra N. 2021. The lower expression of circulating miR-210 and elevated serum levels of HIF-1α in ischemic stroke; possible markers for diagnosis and disease prediction. J Clin Lab Anal. 35(12):240–253.
  • Ren CX, Leng RX, Fan YG, Pan HF, Wu CH, Ye DQ. 2016. MicroRNA-210 and its theranostic potential. Expert Opin Ther Targets. 20(11):1325–1338.
  • Rust R. 2020. Insights into the dual role of angiogenesis following stroke. J Cereb Blood Flow Metab. 40(6):1167–1171.
  • Sun X. 2010. Research on formula treating paralysis and spasticity from treatise on febrile and miscellaneous diseases. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi. 8:644–645.
  • Uemura MT, Maki T, Ihara M, Lee VMY, Trojanowski JQ. 2020. Brain microvascular pericytes in vascular cognitive impairment and dementia. Front Aging Neurosci. 12:80.
  • Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM. 2005. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain. 128(Pt 1):52–63.
  • Wang J, Shi Y, Zhang L, Zhang F, Hu X, Zhang W, Leak RK, Gao Y, Chen L, Chen J. 2014. Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke. Neurobiol Dis. 68:91–103.
  • Xiang Y, Yao X, Wang X, Zhao H, Zou H, Wang L, Zhang QX. 2019. Houshiheisan promotes angiogenesis via HIF-1α/VEGF and SDF-1/CXCR4 pathways: in vivo and in vitro. Biosci Rep. 39:BSR20191006.
  • Xu W, Huang M, Li H, Chen X, Zhang Y, Liu J, Xu W, Chu K, Chen L. 2015. Chemical profiling and quantification of Gua-Lou-Gui-Zhi decoction by high performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and ultra-performance liquid chromatography/triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 986–987:69–84.
  • Yang C, Chen L, Tao J. 2013. New usage of a classical formula—Gua Lou Gui Zhi decoction. Liaoning Zhong Yi Za Zhi. 8:166–167.
  • Yu ZP, Yu HQ, Li J, Li C, Hua X, Sheng XS. 2020. Troxerutin attenuates oxygen-glucose deprivation and reoxygenation-induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF-1α signaling pathway in H9C2 cardiomyocytes. Mol Med Rep. 22(2):1351–1361.
  • Zhang L, Ai H. 2005. Effects of Gua Lou Gui Zhi decoction on c-fos and c-jun in epileptic rats. Sichuan Huaxi Zhong Yi YaoYan Jiu Suo. 23:21–22.
  • Zhang Y, Fan L, Li H, Wang X, Xu W, Chu K, Lin Y. 2018. Gualou Guizhi granule protects against oxidative injury by activating Nrf2/ARE pathway in rats and PC12 cells. Neurochem Res. 43(5):1003–1009.
  • Zhang YQ, Huang L, Xu W, Xu W, Huang M, Chu KD, Chen LD. 2015. Effects of Gualou Guizhi granule on blood brain barrier permeability and neuroprotection in cerebral ischemia–reperfusion injury rat. Chin J Tradit Chin Med. 30:40–47.
  • Zhang Y, Li H, Huang M, Chu K, Xu W, Zhang S, Que J, Chen L. 2014. Neuroprotective effects of Gualou Guizhi decoction in vivo and in vitro. J Ethnopharmacol. 158:76–84.
  • Zhang YQ, Li Z, Li H, Xu W, Chu KD, Huang TT, Lin Y. 2017. Effect of Gualou Guizhi granule in active Nrf2 pathway and alleviating oxidative stress in rats with cerebral ischemia–reperfusion injury. Chin J Exp Tradit Med Formulae. 23:112–116.
  • Zhang Y, Wang H, Li H, Nan L, Xu W, Lin Y, Chu K. 2021. Gualou Guizhi granule protects against OGD/R-induced injury by inhibiting cell pyroptosis via the PI3K/Akt signaling pathway. Evid Based Complement Alternat Med. 2021:6613572.
  • Zhu Y. 2015. Clinical effect of analysis of Trichosanthes kirilowii cassia twig decoction for treatment of lower limb spasm after cerebral apoplexy patients. Chin Med J. 13:27–28.